ShareValue scores for 301126.SHE: Valuation 64, Quality 14, Growth 57, Health 33.

301126.SHE
SZSE

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

CN¥9.58(+2.68%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 19%
Valuation
64
Fair Value
Price vs Value
Quality
14
Weak
Business Strength
Growth
57
Moderate
Revenue & Earnings
Health
33
Stressed
Financial Stability
Momentum
31
Bearish
Price Trend

Company Details

About

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products. In addition, it provides pharmaceutical logistics services; and operates reproductive hospitals. The company was formerly known as Hunan Tongjian Pharmacy CO., LTD and changed its name to Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd in August 2016. Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd was founded in 2002 and is headquartered in Changsha, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026